Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Santhera
Biotech
Destiny ends COVID collab, Santhera returns lonodelestat
Both Destiny and Santhera explained why a tighter clinical focus comes at the expense of one of their potential assets
James Waldron
Apr 25, 2024 8:23am
Santhera offloads North American rights for DMD med to Catalyst
Jun 20, 2023 9:53am
Santhera loses interest in pulmonary drug to focus on DMD
Oct 31, 2022 10:25am
Santhera sidelined by manufacturing delay for DMD drug
Jun 29, 2022 10:55am
Novartis alums unveil their next act—Chutes & Ladders
Nov 6, 2020 9:30am
Santhera outlines cuts, and they are deep, as CMO hits the exit
Nov 2, 2020 7:35am